Trials / Completed
CompletedNCT05742867
A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder
Patient Preferences of Treatment for the Patients Suffering From Muscle-invasive Urothelial Carcinoma of Bladder Following Radical Cystectomy in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The main purpose of this study is to identify important treatment attributes for post-radical cystectomy (RC) treatment for participants with MIBC (Muscle-Invasive Bladder Cancer) and assess the relative importance of treatment attributes for post-RC treatment in Japan.
Conditions
Timeline
- Start date
- 2023-05-31
- Primary completion
- 2024-07-10
- Completion
- 2024-07-10
- First posted
- 2023-02-24
- Last updated
- 2025-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05742867. Inclusion in this directory is not an endorsement.